• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
Thoratec Corporation, together with its subsidiaries, develops, manufactures, and markets proprietary medical devices used for mechanical circulatory support for the treatment of heart failure patients.
Market Cap | 3.442 Billion | Shares Outstanding | 54.2 Million | Avg 30-day Volume | 1.142 Million |
P/E Ratio | 62.9913 | Dividend Yield | 0.0 | EPS | 0.44 |
Price to Revenue | 5.0475 | Debt to Equity | 0.0085 | EBITDA | 73.011 Million |
Price to Book Value | 3.5899 | Operating Margin | 11.1974 | Enterprise Value | 2.17 Billion |
Current Ratio | 5.536 | EPS Growth | -0.393 | Quick Ratio | 4.25 |
1 Yr BETA | 0.4891 | 52-week High/Low | 0.0 / | Profit Margin | 8.013 |
Operating Cash Flow Growth | -7.728 | Altman Z-Score | 12.1415 | Free Cash Flow to Firm | 23.3 Million |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
SHAWVER LAURA PRESIDENT AND CEO |
|
105,706 | 2019-01-24 | 0 |
|
0 | 2018-12-19 | 0 | |
|
0 | 2018-12-06 | 0 | |
|
0 | 2018-12-06 | 0 | |
|
0 | 2018-12-06 | 0 | |
|
0 | 2018-12-06 | 0 | |
|
187,237 | 2018-12-06 | 0 | |
|
0 | 2018-12-06 | 0 | |
|
187,237 | 2018-12-06 | 0 | |
|
62,412 | 2018-12-06 | 0 | |
LEVEQUE JOSEPH CHIEF MEDICAL OFFICER |
|
259,365 | 2018-12-06 | 0 |
REARDON TIGHE ACTING CHIEF FINANCIAL OFFICER |
|
43,688 | 2018-12-06 | 0 |
|
280,856 | 2018-12-06 | 0 | |
MILLA MARCOS CHIEF SCIENTIFIC OFFICER |
|
0 | 2018-12-06 | 0 |
|
No longer subject to file | 2015-10-08 | 0 | |
|
No longer subject to file | 2015-10-08 | 0 | |
|
No longer subject to file | 2015-10-08 | 0 | |
|
No longer subject to file | 2015-10-08 | 0 | |
|
No longer subject to file | 2015-10-08 | 0 | |
GROSSMAN D KEITH PRESIDENT & CHIEF EXEC OFFICER |
|
No longer subject to file | 2015-10-08 | 0 |
|
No longer subject to file | 2015-10-08 | 0 | |
LEHMAN DAVID AARON SVP AND GENERAL COUNSEL |
|
No longer subject to file | 2015-10-08 | 0 |
|
No longer subject to file | 2015-10-08 | 0 | |
HARRIS TAYLOR C. VP, CHIEF FINANCIAL OFFICER |
|
No longer subject to file | 2015-10-08 | 0 |
PADMANABHAN VASANT SVP, TECHNICAL OPERATIONS |
|
No longer subject to file | 2015-10-08 | 0 |
PELLEGRINI NIAMH LOUISE PRESIDENT, NORTH AMERICA |
|
No longer subject to file | 2015-10-08 | 0 |
ANTONUCCI MARTA PRESIDENT, INTERNATIONAL |
|
No longer subject to file | 2015-10-08 | 0 |
BURBACH GERHARD F CHIEF EXECUTIVE OFFICER |
|
169,970 | 2014-03-17 | 0 |
|
18,799 | 2013-10-31 | 0 | |
|
24,284 | 2013-05-20 | 0 | |
OULMAN ROXANNE VP OF FINANCE, INTERIM CFO |
|
26,222 | 2012-09-06 | 0 |
SMITH DAVID V CFO & EVP |
|
64,591 | 2011-03-15 | 0 |
COHEN LAWRENCE DIVISION PRESIDENT |
|
32,329 | 2010-06-10 | 0 |
|
920,208 | 2009-02-23 | 0 | |
|
4,339,099 | 2008-11-13 | 0 | |
|
11,250 | 2008-08-04 | 0 | |
|
151,591 | 2007-02-27 | 0 | |
|
804,205 | 2007-02-20 | 0 | |
NELSON JEFFREY DIVISION PRESIDENT |
|
8,422 | 2007-01-12 | 0 |
LUCCHESE CYNTHIA L CHIEF FINANCIAL OFFICER |
|
22,224 | 2006-03-31 | 0 |
TAYLOR BETH A VP, ADMINISTRATION |
|
23,335 | 2006-03-31 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|
Holder | Issuer | Net Short Position | Position Date | Origin |
---|